CME
What Is the Evidence for ADCs in HR-/HER2-Low Metastatic Breast Cancer?
July 21, 2023
Host: Sara M. Tolaney MD, MPH This program provides education to help clinicians confidently diagnose and make informed clinical decisions with their patients, ultimately enhancing clinical outcomes in the evolving treatment landscape of ADCs ac
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast
Gain access to Blubrry tools that help build your podcast, including free podcast stats!